Romvimza 20 MG capsule UU 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FXR9R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,231
Award facts
- Contract value 100% obligated
- $17,230.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,230.53 to AmerisourceBergen Drug Corp for Romvimza 20 mg capsules on February 4, 2026, with an ultimate completion date of February 26, 2026. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 and extending through December 2031, serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a major pharmaceutical distributor and critical federal medical procurement vendor. The company demonstrates substantial capability in fulfilling government contracts for essential pharmaceutical commodities required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order for Romvimza, a pharmaceutical product, exemplifies the company's role in supplying specialized medications across multiple therapeutic domains to support military and federal healthcare systems through competitively awarded, firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26FXR9R?
SPE2DR26FXR9R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FXR9R worth?
The government has obligated $17,231 on SPE2DR26FXR9R.
Is contract SPE2DR26FXR9R an order under another contract?
Yes. SPE2DR26FXR9R is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR9R competed?
The extent of competition for SPE2DR26FXR9R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award